1
The Effect of Arsenic Trioxide on Eliminating HIV-1 Reservoir Combined With cART
Condition(s):HIV/AIDSLast Updated:September 14, 2022Recruiting
Arsenic Trioxide: 146 Clinical Trials, Page 1 of 15
Hide Studies Not Open or Pending
2
Arsenic Trioxide for Structural p53 Mutations
Condition(s):Arsenic Trioxide; p53 Mutations; Refractory Cancer; Intractable CancerLast Updated:January 6, 2021Unknown status
3
Oral Arsenic Trioxide for NPM1-mutated AML
Condition(s):NPMc+ AMLLast Updated:October 4, 2022Recruiting
4
Treatment of Chronic Graft Versus Host Disease With Arsenic Trioxide
Condition(s):Chronic Graft-Versus-Host Disease; Immune System DiseasesLast Updated:May 9, 2022Completed
5
Frontline Oral Arsenic Trioxide for APL
Condition(s):Acute Promyelocytic LeukemiaLast Updated:May 23, 2023Recruiting
6
Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation
Condition(s):Ovarian Cancer; Endometrial CancerLast Updated:July 28, 2020Unknown status
7
Oral Arsenic Trioxide for Newly Diagnosed Acute Promyelocytic Leukaemia
Condition(s):Acute Promyelocytic LeukemiaLast Updated:October 4, 2022Recruiting
8
Trisenox® in Women With Metastatic Endometrial Cancer
Condition(s):Endometrial CarcinomaLast Updated:June 14, 2017Terminated
9
Icotinib and Arsenic Trioxide in Treating Non-small-cell Lung Cancer Patients With Resistance to EGFR-TKI
Condition(s):Non-small Cell Lung CancerLast Updated:March 13, 2015Unknown status
10
Phase II Study of Combined Chemotherapy With Arsenic Trioxide in Stage 4/M Neuroblastoma
Condition(s):NeuroblastomaLast Updated:November 8, 2022Recruiting